Nonalcoholic steatohepatitis (NASH) is a progressive form of fatty liver disease in which excess fat accumulation in the liver leads to inflammation and liver cell damage. Unlike alcoholic liver disease, NASH occurs in people who drink little to no alcohol. Over time, persistent inflammation can cause fibrosis (scarring) and, if untreated, may progress to cirrhosis or liver failure. The ICD-10 code for NASH is K75.81.
In its early stages, NASH often causes no noticeable symptoms. As inflammation and scarring increase, you may experience:
Several factors contribute to the development of NASH, including:
When it comes to Nonalcoholic Steatohepatitis (NASH) care, GastroDoxs in Jersey Village offers you a patient-focused approach backed by the latest research and advanced diagnostic tools. Our experienced team creates customized treatment plans, from lifestyle guidance to cutting-edge clinical trials, ensuring you receive comprehensive support every step of the way. Ready to take control of your liver health? Call us today at 832-632-4070 or book your appointment online to get started.
We've successfully treated more than 1K patients, helping individuals improve their digestive health and overall well-being through expert, personalized care.
With over 20 years of experience, GastroDoxs has been a trusted provider of gastroenterology care, focusing on delivering the best outcomes for patients
Dr. Bharat Pothuri is a Board-Certified Gastroenterologist and Hepatologist. With extensive experience in digestive health, he specializes in advanced endoscopic procedures, chronic GI disorder management, and preventive care. Dr. Pothuri is dedicated to providing expert, patient-focused insights to help improve gut health and overall well-being.
NAFLD (Nonalcoholic Fatty Liver Disease) refers to fat accumulation in the liver without inflammation, while NASH (Nonalcoholic Steatohepatitis) includes both excess fat and inflammation that can damage liver cells.
Early symptoms may include mild fatigue, a dull ache or discomfort in the upper right abdomen, unexplained weight loss, or loss of appetite. Many patients, however, remain asymptomatic.
Risk factors include obesity, type 2 diabetes, insulin resistance, high cholesterol or triglycerides, metabolic syndrome, rapid weight gain, certain medications, and genetic predisposition.
Diagnosis typically involves elevated liver enzymes on blood tests, imaging studies such as ultrasound or FibroScan, and sometimes a liver biopsy to confirm inflammation and fibrosis. The ICD-10 code is K75.81.
Yes. Several research trials are underway testing new therapies for NASH. Ask our team about current studies and eligibility criteria.
Yes. Losing 5-10% of your body weight through diet and exercise has been shown to reduce liver fat, inflammation, and slow disease progression.
There are no FDA-approved drugs specifically for NASH yet, but medications used for diabetes, cholesterol, or blood pressure management can sometimes help reduce liver fat and inflammation.
Follow-up visits are typically recommended every 6-12 months, or more frequently if there are signs of advancing fibrosis or cirrhosis.
GastroDoxs in Jersey Village offers same-day and next-day appointments with experienced hepatologists and gastroenterologists specializing in NASH care.
GastroDoxs provides comprehensive NASH care from initial diagnosis through long-term monitoring and treatment, all conveniently located in Jersey Village.
